ID   SK-GT-1
AC   CVCL_9585
SY   SKGT1
DR   IARC_TP53; 4077
DR   Wikidata; Q54953658
RX   PubMed=7665247;
RX   PubMed=8334620;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=8334620).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.169_185del17; Zygosity=Unspecified (PubMed=7665247).
CC   Derived from site: In situ; Stomach, cardia; UBERON=UBERON_0001162.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=7665247; DOI=10.1002/ijc.2910640109;
RA   Nabeya Y., Loganzo F. Jr., Maslak P., Lai L., de Oliveira A.R.,
RA   Schwartz G.K., Blundell M.L., Altorki N.K., Kelsen D.P., Albino A.P.;
RT   "The mutational status of p53 protein in gastric and esophageal
RT   adenocarcinoma cell lines predicts sensitivity to chemotherapeutic
RT   agents.";
RL   Int. J. Cancer 64:37-46(1995).
//
RX   PubMed=8334620; DOI=10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L;
RA   Altorki N.K., Schwartz G.K., Blundell M.L., Davis B.M., Kelsen D.P.,
RA   Albino A.P.;
RT   "Characterization of cell lines established from human gastric-esophageal
RT   adenocarcinomas. Biologic phenotype and invasion potential.";
RL   Cancer 72:649-657(1993).
//